| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱(chēng)及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
|---|---|---|---|---|---|---|---|
| 111451-25MG |
|
1242066-20-1 |
(R)-3,3'-雙(1-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,- |
25MG | 需詢(xún)價(jià) | C40H33O4P | |
| 110262-1G |
|
NA |
(S)-3,3'-雙(2-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C40H33O4P | |
| 110262-100MG |
|
NA |
(S)-3,3'-雙(2-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C40H33O4P | |
| 110262-25MG |
|
NA |
(S)-3,3'-雙(2-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C40H33O4P | |
| 110261-1G |
|
922711-75-9 |
(R)-3,3'-雙(2-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C40H33O4P | |
| 110261-100MG |
|
922711-75-9 |
(R)-3,3'-雙(2-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C40H33O4P | |
| 110261-25MG |
|
922711-75-9 |
(R)-3,3'-雙(2-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C40H33O4P | |
| 110252-1G |
|
NA |
(S)-3,3'-雙[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C36H25F12O4P | |
| 110252-100MG |
|
NA |
(S)-3,3'-雙[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C36H25F12O4P | |
| 110252-25MG |
|
NA |
(S)-3,3'-雙[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C36H25F12O4P | |
| 110251-1G |
|
1011465-24-9 |
(R)-3,3'-雙[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C36H25F12O4P | |
| 110251-100MG |
|
1011465-24-9 |
(R)-3,3'-雙[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C36H25F12O4P | |
| 110251-25MG |
|
1011465-24-9 |
(R)-3,3'-雙[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C36H25F12O4P | |
| 110242-1G |
|
NA |
(S)-3,3'-雙(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C36H37O4P | |
| 110242-100MG |
|
NA |
(S)-3,3'-雙(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C36H37O4P | |
| 110242-25MG |
|
NA |
(S)-3,3'-雙(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bS)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C36H37O4P | |
| 110241-1G |
|
1065214-95-0 |
(R)-3,3'-雙(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C36H37O4P | |
| 110241-100MG |
|
1065214-95-0 |
(R)-3,3'-雙(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C36H37O4P | |
| 110241-25MG |
|
1065214-95-0 |
(R)-3,3'-雙(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯(lián)萘酚磷酸酯 (11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C36H37O4P | |
| 100692-1G |
|
1193697-61-8 |
(S)-5,5',6,6',7,7',8,8'-八氫聯(lián)萘酚磷酸酯 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C20H21O4P | |
小泰
|
010-60710855
|